Overview
The aim of this clinical study is to compare the effects of tDCS, physiotherapy, and their association with the intensity and frequency of pain in women with Chronic Migraine. For this purpose, the patients included in the study will be distributed among four groups following a factorial model.
Description
A factorial, randomized clinical trial will be conducted to evaluate pain control, the number of migraine attacks, quality of life, emotional dysfunctions, and attentional processing of migraine patients.
Clinical outcomes will be evaluated through (I) a Visual Analog Scale (VAS); (II) a headache diary; (III) a Headache Impact Test (HIT-6); (IV) a Migraine Disability Assessment (MIDAS); (V) Short-Form Health Survey Questionnaire de 36 items (SF-36); (VI) Patients' Global Impression of Change Scale (PGICS); (VII) Beck Depression Inventory (BDI); (VIII) State-Trait Anxiety Inventory (S-TAI); (IX) Perceived Stress Scale (PSS); and (X) Facial Expression Database.
Eligibility
Inclusion Criteria:
- Women;
- 18-50 years old;
- with Chronic Migraine according to ICHD-3 beta;
- literate;
- without excessive use of headache medications, not undergoing other types of non-pharmacological interventions for CM, not lactating or pregnant, not having associated neurological or neuropsychiatric diseases, without other types of headache, without rheumatic diseases, without signs and/or symptoms of spinal radiculopathy, without metallic implants located in the head and/or cochlear implants.
Exclusion Criteria:
- started a new pharmacological treatment for migraine less than 3 months before participating in the study or modifying the administration of continuous medication during the research
- who perhaps become pregnant during the execution of the clinical trial
- present some disease that disables their continuity in the treatment
- start another type of treatment
- show changes in physical activity and/or eating routine during the research
- has severe depression (BDI > 35).